Tuesday, February 24, 2026 | 07:25 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Sohini Das

Sohini Das

Sohini Das

Sohini Das writes on automobile and healthcare sectors for Business Standard. Over her 17 years as a journalist, she has covered multiple sectors and issues -- FMCG, dairy, tourism, and state elections, among others, across Kolkata, Ahmedabad, and Mumbai. She loves doing personality stories and ground reportage.

Sohini Das writes on automobile and healthcare sectors for Business Standard. Over her 17 years as a journalist, she has covered multiple sectors and issues -- FMCG, dairy, tourism, and state elections, among others, across Kolkata, Ahmedabad, and Mumbai. She loves doing personality stories and ground reportage.

Email
Twitter
LinkedIn

Page 80 - Sohini Das

Haven't received any payment from Brazilian health ministry: Bharat Biotech

Madison Biotech was founded by Krishna Ella in 2020 for external R&D, sales and marketing of vaccines

Haven't received any payment from Brazilian health ministry: Bharat Biotech
Updated On : 01 Jul 2021 | 2:15 AM IST

Cipla gets DCGI nod to import Moderna vaccine; no commercial deal yet

1st mRNA vax part of US-India pact; no commercial deal yet

Cipla gets DCGI nod to import Moderna vaccine; no commercial deal yet
Updated On : 30 Jun 2021 | 1:37 AM IST

We are thinking of a mega-app for Manipal Hospitals: Dilip Jose, MD&CEO

"Such a move would enable us to have virtual presence in regions where we do not yet have a physical presence, for example, the North Eastern states," said Jose

We are thinking of a mega-app for Manipal Hospitals: Dilip Jose, MD&CEO
Updated On : 30 Jun 2021 | 12:23 AM IST

Serum Institute applies for EU nod through drugmaker AstraZeneca

SII Chief Executive Officer Adar Poonawalla said on Mon­day he had taken it up at the "highest levels".

Serum Institute applies for EU nod through drugmaker AstraZeneca
Updated On : 29 Jun 2021 | 11:03 PM IST

Moderna vaccine is first mRNA jab to get emergency-use nod in India

Path cleared for importing foreign regulator-approved vaccines without bridging clinical studies; Moderna jab has 94.1% efficacy

Moderna vaccine is first mRNA jab to get emergency-use nod in India
Updated On : 29 Jun 2021 | 7:17 PM IST

African Union urges EU to expand vax list to include WHO-Covax vaccines

The African countries have received the Covishield jab from WHO-led Covax

African Union urges EU to expand vax list to include WHO-Covax vaccines
Updated On : 29 Jun 2021 | 1:36 PM IST

Rs 50,000-cr loan guarantee for health not enough in non-metros: Industry

Finance Minister Nirmala Sithar­aman said the government would provide 75 per cent coverage for new projects and 50 per cent for those in expansion mode in the non-metros

Rs 50,000-cr loan guarantee for health not enough in non-metros: Industry
Updated On : 29 Jun 2021 | 1:47 AM IST

More than 50% kids in Mumbai have Covid-19 antibodies: Sero-survey

Seropositivity is highest in the age group 10-14 years, at 53.43 per cent

More than 50% kids in Mumbai have Covid-19 antibodies: Sero-survey
Updated On : 29 Jun 2021 | 12:44 AM IST

Bajaj Healthcare seeks compulsory licence for Covid-19 drug Baricitinib

Eli Lilly has granted voluntary license to 6 Indian drugmakers for Baricitinib

Bajaj Healthcare seeks compulsory licence for Covid-19 drug Baricitinib
Updated On : 28 Jun 2021 | 11:40 PM IST

DRL launches DRDO drug 2-DG to treat moderate to severe Covid patients

2-DG was developed by the Institute of Nuclear Medicine & Allied Sciences (INMAS), a laboratory of the Defence Research and Development Organisation (DRDO), in collaboration with Dr Reddy's

DRL launches DRDO drug 2-DG to treat moderate to severe Covid patients
Updated On : 28 Jun 2021 | 11:37 PM IST

Taken up Covishield travel issue at highest levels: Adar Poonawalla

Reports suggest India plans to take this matter of non-inclusion of Covishield in the list of approved vaccines for European Union (EU) 'Green Pass' up with the EU

Taken up Covishield travel issue at highest levels: Adar Poonawalla
Updated On : 28 Jun 2021 | 11:35 PM IST

Govt announces Rs 50,000 cr loan guarantee scheme for health infra

Additional Rs 23,220 crore allocated with a primary focus on paediatric care

Govt announces Rs 50,000 cr loan guarantee scheme for health infra
Updated On : 28 Jun 2021 | 6:12 PM IST

Centre adds over 32,000 cold chain equipment since March last year

There are 37 state vaccine stores, 114 regional vaccine stores, 723 district vaccine stores and 28,268 sub-district vaccine stores

Centre adds over 32,000 cold chain equipment since March last year
Updated On : 28 Jun 2021 | 12:25 AM IST

51% of Covid-19 vaccinations in May-June have been in rural centres

In terms of total Covid vaccinations by states, Uttar Pradesh, Maharastra, Rajasthan, West Bengal have fared strongly

51% of Covid-19 vaccinations in May-June have been in rural centres
Updated On : 28 Jun 2021 | 12:17 AM IST

Zydus Covid-19 vaccine doses may be out soon for adolescents: Govt

Says 1.35 bn doses will be available between Aug-Dec; 160 mn doses are expected between May and July

Zydus Covid-19 vaccine doses may be out soon for adolescents: Govt
Updated On : 28 Jun 2021 | 12:12 AM IST

Covid-19 vaccination: Fear, myths & rumours inject vaccine hesitancy

Govts, NGOs and corporations try to get fence-sitters to take the jab

Covid-19 vaccination: Fear, myths & rumours inject vaccine hesitancy
Updated On : 27 Jun 2021 | 11:21 PM IST

Not insisting on board seat; only an investor: Thyrocare's A Velumani

I am an investor, and not insisting on any board seat. I am selling my entire stake of 66 per cent, says Velumani

Not insisting on board seat; only an investor: Thyrocare's A Velumani
Updated On : 28 Jun 2021 | 6:10 AM IST
PharmEasy parent to acquire 66% stake in Thyrocare for Rs 4,546 cr
Updated On : 26 Jun 2021 | 10:26 AM IST

Covid vaccine: Sputnik V may not be available in India for another 2 weeks

Around 3 million units of the first dose of the vaccine have landed in India, while the consignment of the second dose is expected by the end of this month.

Covid vaccine: Sputnik V may not be available in India for another 2 weeks
Updated On : 26 Jun 2021 | 6:10 AM IST

Serum Institute starts Covovax production; govt expects 200 mn doses by Dec

India will allow entry of this vaccine once the USFDA approves it

Serum Institute starts Covovax production; govt expects 200 mn doses by Dec
Updated On : 25 Jun 2021 | 11:45 PM IST